Posts Tagged: acacia research


Public vs. Private IP Companies – Challenges and Opportunities

At the very beginning of the program Siegel, during his opening remarks, said: "At Acacia we are not in the litigation business, we are in the licensing …
10 months ago 1

Exclusive Interview with Jaime Siegel of Acacia Research

Siegel: "I think this effort to destroy the value of intellectual property is a bigger wet towel on innovation. When startup companies, after they get their angel …
10 months ago 3

Patent Business: Litigation, Deals, Licenses & Settlements

Pitney Bowes and IBM to Collaborate on Hybrid Cloud Location Services ***** Patent Lawsuits Filed Over 3D Cinema Projection Technology ***** Microsoft and Dell Sign Patent Licensing Agreement ***** Tessera …
1 year ago 0

Patent Business: Deals, Settlements, Licenses – January 2013

The month of January started off quite busy, which in all likelihood was as the result of deals and announcements either held over or that simply couldn't …
3 years ago 0

Exclusive Interview: Paul Ryan, CEO of Acacia Research

Paul Ryan is a more common name than you might think. In the world of politics when one speaks of "Paul Ryan" they are talking about the …
3 years ago 5

Patent Litigation Settlement Roundup – Nov. 16, 2012

Acacia announced that the Company’s Board of Directors has authorized a program for repurchasing shares of the Company’s outstanding common stock. The stock repurchase program …
3 years ago 0

Patent Litigation Settlement Roundup

On November 8, 2012, Mylan Inc. (Nasdaq: MYL) announced that it, along with Famy Care Ltd., has entered into a settlement agreement with Janssen Pharmaceuticals Inc. that will resolve …
3 years ago 0

Article One Targets Patent Owned by Acacia Research

One of the newer prior art research studies currently underway at Article One Partners is one that relates to U.S. Patent No. 6,332,158, which relates to a …
3 years ago 2

Patent Business: Deals, Acquisitions & Licenses July 2012

This deal will give GSK exclusive rights to BENLYSTA, which is a human monoclonal antibody that inhibits B-cell activating factor (BAFF) approved for treatment of systemic lupus …
3 years ago 0

Patent Business: Deals, Acquisitions & Licenses Vol. 1

Merck and AstraZeneca Agree to Amend Partnership - Theradiag Acquires Innovative MicroRNA Technology Platform - 8x8 Sells Patent Family - MPEG LA Announces Call for Patents Essential …
3 years ago 1

Patent Mass Aggregators: The Giants Among Us

The types of returns promised to investors and the types of benefits offered to participants are also quite different from garden-variety non-practicing entities, as are some of …
4 years ago 21

Acacia Research by the Numbers: Inside the Belly of the Beast

Acacia has long been considered by many to be the mother of all patent trolls. But are they really a patent troll? The term "patent troll" is …
4 years ago 2